Roles of the immune system in cancer: from tumor initiation to metastatic progression
- PMID: 30275043
- PMCID: PMC6169832
- DOI: 10.1101/gad.314617.118
Roles of the immune system in cancer: from tumor initiation to metastatic progression
Abstract
The presence of inflammatory immune cells in human tumors raises a fundamental question in oncology: How do cancer cells avoid the destruction by immune attack? In principle, tumor development can be controlled by cytotoxic innate and adaptive immune cells; however, as the tumor develops from neoplastic tissue to clinically detectable tumors, cancer cells evolve different mechanisms that mimic peripheral immune tolerance in order to avoid tumoricidal attack. Here, we provide an update of recent accomplishments, unifying concepts, and future challenges to study tumor-associated immune cells, with an emphasis on metastatic carcinomas.
Keywords: cancer heterogeneity; disseminated tumor cells; immune cross-talk; metastasis-associated immune cells; patient-derived xenograft; tumor-associated macrophages.
© 2018 Gonzalez et al.; Published by Cold Spring Harbor Laboratory Press.
Figures
![Figure 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6169832/bin/1267f01.gif)
![Figure 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6169832/bin/1267f02.gif)
![Figure 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6169832/bin/1267f03.gif)
![Figure 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6169832/bin/1267f04.gif)
Similar articles
-
Innate and acquired immune surveillance in the postdissemination phase of metastasis.FEBS J. 2018 Feb;285(4):654-664. doi: 10.1111/febs.14325. Epub 2017 Nov 24. FEBS J. 2018. PMID: 29131550 Free PMC article. Review.
-
Immune surveillance: a balance between protumor and antitumor immunity.Curr Opin Genet Dev. 2008 Feb;18(1):11-8. doi: 10.1016/j.gde.2007.12.007. Epub 2008 Mar 4. Curr Opin Genet Dev. 2008. PMID: 18308558 Free PMC article. Review.
-
Redefining macrophage and neutrophil biology in the metastatic cascade.Immunity. 2021 May 11;54(5):885-902. doi: 10.1016/j.immuni.2021.03.022. Immunity. 2021. PMID: 33979586 Review.
-
[Prognostic value of tumor-infiltrating immune cells in melanoma].Magy Onkol. 2013 Jun;57(2):85-95. Epub 2013 Apr 3. Magy Onkol. 2013. PMID: 23795353 Review. Hungarian.
-
[Suppressor cells - the basis of the immunopathogenesis of cancer].Vopr Onkol. 2016;62(3):390-6. Vopr Onkol. 2016. PMID: 30462899 Review. Russian.
Cited by
-
CT-based radiomics nomogram to predict proliferative hepatocellular carcinoma and explore the tumor microenvironment.J Transl Med. 2024 Sep 2;22(1):683. doi: 10.1186/s12967-024-05393-3. J Transl Med. 2024. PMID: 39218938
-
Advances in siRNA Drug Delivery Strategies for Targeted TNBC Therapy.Bioengineering (Basel). 2024 Aug 14;11(8):830. doi: 10.3390/bioengineering11080830. Bioengineering (Basel). 2024. PMID: 39199788 Free PMC article. Review.
-
A novel model based on lipid metabolism-related genes associated with immune microenvironment predicts metastasis of breast cancer.Discov Oncol. 2024 Aug 27;15(1):372. doi: 10.1007/s12672-024-01253-0. Discov Oncol. 2024. PMID: 39190262 Free PMC article.
-
NLR stability predicts response to immune checkpoint inhibitors in advanced hepatocellular carcinoma.Sci Rep. 2024 Aug 23;14(1):19583. doi: 10.1038/s41598-024-68048-9. Sci Rep. 2024. PMID: 39179639 Free PMC article.
-
Identification of a novel alternative splicing isoform of the Hippo kinase STK3/MST2 with impaired kinase and cell growth suppressing activities.Oncogene. 2024 Aug 22. doi: 10.1038/s41388-024-03104-2. Online ahead of print. Oncogene. 2024. PMID: 39174858
References
-
- Andrews DM, Sullivan LC, Baschuk N, Chan CJ, Berry R, Cotterell CL, Lin J, Halse H, Watt SV, Poursine-Laurent J, et al. 2012. Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells. Nat Immunol 13: 1171–1177. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical